Toxicity of cadmium in musculoskeletal diseases.


Journal

Environmental toxicology and pharmacology
ISSN: 1872-7077
Titre abrégé: Environ Toxicol Pharmacol
Pays: Netherlands
ID NLM: 9612020

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 26 03 2019
revised: 19 06 2019
accepted: 25 06 2019
pubmed: 9 9 2019
medline: 17 3 2020
entrez: 9 9 2019
Statut: ppublish

Résumé

Epidemiological studies have reported that exposure to toxic metals like cadmium (Cd) may promote the development of musculoskeletal diseases, such as osteoporosis, rheumatoid arthritis (RA), and osteoarthritis (OA), among others. The objective of this review is to summarize the molecular mechanisms of inflammation and oxidative stress activated by Cd at the bone level, particularly in osteoporosis, RA, and OA. Cadmium can increase bone resorption, affect the activity of osteoclasts and calcium (Ca) absorption, and impair kidney function, which favors the development of osteoporosis. In the case of RA, Cd interferes with the activity of antioxidant proteins, like superoxide dismutase (SOD) and catalase (CAT). It also promotes an inflammatory state, inducing the process of citrullination, which affects the proteins of immune response. On the other hand, accumulation of Cd in the tissues and blood of smokers has been related to the development of some musculoskeletal diseases. Therefore, knowing the negative impact of Cd toxicity at the articular level can help understand the damage mechanisms it produces, leading to the development of such diseases.

Identifiants

pubmed: 31494513
pii: S1382-6689(19)30090-0
doi: 10.1016/j.etap.2019.103219
pii:
doi:

Substances chimiques

Environmental Pollutants 0
Cadmium 00BH33GNGH

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103219

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

D Reyes-Hinojosa (D)

Synovial Fluid Laboratory, National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", Calzada Mexico-Xochimilco 289, C.P. 14389, Mexico City, Mexico.

C A Lozada-Pérez (CA)

Rheumatology Service, National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico.

Y Zamudio Cuevas (Y)

Synovial Fluid Laboratory, National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", Calzada Mexico-Xochimilco 289, C.P. 14389, Mexico City, Mexico.

A López-Reyes (A)

Synovial Fluid Laboratory, National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", Calzada Mexico-Xochimilco 289, C.P. 14389, Mexico City, Mexico.

G Martínez-Nava (G)

Synovial Fluid Laboratory, National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", Calzada Mexico-Xochimilco 289, C.P. 14389, Mexico City, Mexico.

J Fernández-Torres (J)

Synovial Fluid Laboratory, National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", Calzada Mexico-Xochimilco 289, C.P. 14389, Mexico City, Mexico.

A Olivos-Meza (A)

Orthopedic Sports Medicine and Arthroscopy Service, National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico.

C Landa-Solis (C)

Tissue Engineering Cell Therapy and Regenerative Medicine Unit, National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico.

M C Gutiérrez-Ruiz (MC)

Department of Health Sciences, Autonomous Metropolitan University, Mexico City, Mexico; Laboratory of Experimental Medicine, Unit of Translational Medicine, Institute of Biomedical Research, UNAM, National Institute of Cardiology "Ignacio Chávez", Mexico City, Mexico.

E Rojas Del Castillo (E)

Departament of Genomic Medicine and Environmental Toxicology, Institute of Biomedical Research, UNAM, Mexico City, Mexico.

K Martínez-Flores (K)

Synovial Fluid Laboratory, National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", Calzada Mexico-Xochimilco 289, C.P. 14389, Mexico City, Mexico. Electronic address: karinabiologist@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH